Delivery Order SPE2DB20D9331-SPE2DB25FL1Y1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,584.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, does not utilize any set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $46,683.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of August 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,224.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of...
- The Defense Logistics Agency awarded a delivery order valued at $4,475.16 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of VABYSMO 6 mg/0.05 ml syringes. VABYSMO is a prescription pharmaceutical product used in ophthalmology for treating retinal conditions. The delivery order is firm fixed price with no set-aside designation and is scheduled for ultimate completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. This delivery order is issued...
- This is a $6,224.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, with a period of performance through November 7, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $48,013.50, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a prescription pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, which has a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc. for VABYSMO 6 mg/0.05 ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct procurement of pharmaceutical supplies to support military healthcare operations. VABYSMO is a prescription ophthalmic medication used in treating age-related macular degeneration, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Y1Delivery Order
The Defense Logistics Agency awarded a $29,168 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The award, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the pharmaceutical product to support Department of Defense healthcare operations. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide. VABYSMO, a prescription medication for treating age-related macular degeneration, represents one of the specialized pharmaceutical products within the extensive portfolio covered by the underlying indefinite delivery vehicle. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for branded and generic prescription drugs, biologics, and medical consumables serving military healthcare systems across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.2k | 9/9/25 |